H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: based on the investigation of the returned delivery system the alleged failure to cross the lesion could not be confirmed.The distal section of the system including tip was found in good condition without damage/ deformation indicating crossing difficulty.Images/movies documenting the alleged issue were not provided.The investigation led to an inconclusive evaluation result because the issue could not be re produced; an indication for a manufacturing related issue could not be found.A definite root cause for the reported event could not be determined.Labeling review: in reviewing the relevant labeling for this product, it was found that the instructions for use (ifu) sufficiently addressed the potential risk.The ifu state: 'gain femoral access utilizing a 6 fr (2 mm) or larger introducer sheath.', 'if resistance is met during stent system introduction, the stent system should be withdrawn and another stent system should be used.', and 'gain femoral access utilizing a 6 fr (2 mm) or larger introducer sheath.' regarding pta the ifu state: 'predilation of the lesion should be performed using standard techniques.'.H10: d4(03/2021), g4.H11: h3, h6(results, conclusion).H10: the catalog number identified in section d4 has not been cleared in the u.S.But, it is similar to the lifestent solo vascular stent system products that are cleared in the us.The 510 k number and pro code for the lifestent solo vascular stent system products are identified in d2 and g5.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|